Forum: Financial Investment Forum. - This forum is for financial topics only. Please adhere to forum rules. Violators will be banned from this forum and possibly the entire site.

Thread: what is your opinion on marijuana stocks?

Page 2 of 2 FirstFirst 12
  1. #26  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Solis Tek to Present at Annual Cannabis World Congress & Business Expo https://finance.yahoo.com/news/solis...ity&soc_trk=ma
    Reply With Quote  
     

  2. #27  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Quote Originally Posted by brucefan View Post
    Solis Tek to Present at Annual Cannabis World Congress & Business Expo https://finance.yahoo.com/news/solis...ity&soc_trk=ma
    Grow Lights: Why Cannabis Grows Need a Change -- CFN Media https://finance.yahoo.com/news/grow-...ity&soc_trk=ma
    Reply With Quote  
     

  3. #28  
    my clock is stuck on 420 time to hit this bong brendanjack's Avatar
    Join Date
    Sep 2004
    Location
    montauk the end
    Posts
    1,571
    Solis Tek makes a decent ballast but outside of that there are much better bulbs and reflectors out there. Alot of growers have been going led they run much cooler. biggest problem with hps and metal halide rooms heat up big time. LED is a lot friendlier on kilowatt per hour usage . As long as your getting the proper light lumens and your electric bill is not spiking growers are happier
    Reply With Quote  
     

  4. #29  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Quote Originally Posted by brendanjack View Post
    Solis Tek makes a decent ballast but outside of that there are much better bulbs and reflectors out there. Alot of growers have been going led they run much cooler. biggest problem with hps and metal halide rooms heat up big time. LED is a lot friendlier on kilowatt per hour usage . As long as your getting the proper light lumens and your electric bill is not spiking growers are happier
    Buy the stock. Its going up . They are doing a raise and looking at some very strong Acquisitions
    Reply With Quote  
     

  5. #30  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Independent Research Firm Light Laboratory Inc. Releases First Comprehensive Study on Cannabis Commercial Lighting Solutions https://finance.yahoo.com/news/indep...ity&soc_trk=ma
    Reply With Quote  
     

  6. #31  
    RX Wizard
    Join Date
    Oct 2008
    Location
    ---------
    Posts
    5,406
    technically , marijuana stocks are breaking. Long term, this is as a good as go as possible. In Canada, there is a GROSSLY liberal govt-- so far left, gotta be 2 standard deviations from normal. Trudeau 2 is a liberal's wet dream. Its a go in Canada for the summer of 2018.
    Pinarello (Paris) 2012 , dura-ace c50, shimano ultegra Di2
    Reply With Quote  
     

  7. #32  
    RX Senior smartmoneyfollower's Avatar
    Join Date
    Sep 2005
    Location
    Georgia .. 5 billion BBQ places , one good pizza place in the entire state
    Posts
    2,082
    marijuana stocks are the space where the the billion dollar VC play and Capital Investment Corporations, they buy the companies before they ever go public, Scotts Miracle-Gro Co is the simplest play
    Reply With Quote  
     

  8. #33  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    SOURCE: CFN Media

    September 26, 2017 09:00 ET
    Solis Tek Beats Out Competition in Cannabis Lighting Study -- CFN Media


    SEATTLE, WA--(Marketwired - Sep 26, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article examining Solis Tek Inc. (OTCQB: SLTK) and a recent independent lighting study.
    There's an estimated 1,600 to 2,200 wholesale cannabis cultivation businesses in the United States and over 1,000 dispensaries that grow their own cannabis, according to the Marijuana Business Factbook. Lighting systems are a vital part of any cultivation operation. They typically represent 20-30% of a commercial grower's overall startup cost. Choosing the right lighting technology can impact the quality of a grow and the yield a cultivator gets out his or her garden.
    According to an independent, third-party test of six cannabis-focused lighting companies, Solis Tek Inc.'s (OTCQB: SLTK) digital lighting solutions scored the highest in terms of overall value for cultivators. Analysts expect the U.S. cannabis industry to exceed $50 billion in size over the coming years, following the legalization of recreational marijuana in states like California and Nevada, which creates an enormous opportunity for lighting providers.
    Light Laboratory Study
    Light Laboratory Inc., an independent photometric testing laboratory, evaluated six different cannabis lighting providers to assess which offered the best overall value for cultivators. The study evaluated photosynthetic photon flux density ("PPFD"), which measures the quantity of light that arrives at the plant canopy and how plants "see" and "absorb" light. Higher readings translate to improved plant yields and lower costs for cultivators.
    The study found that Solis Tek's All-In-One A1 fixture had the best light output, providing a high-intensity and a more consistent footprint than competing options. In other words, the lighting solutions help commercial growers avoid hotspots and create a more even canopy, where no one plant grows taller and overshadows other plants. This helps anyone interested in growing cannabis plants create the best environment to increase yield.
    Solis Tek's unique four spectrum "light diet" targets specific growth cycles and replicates the different seasons of the year, where the plants make use of natural light in different ways. The company was the first cannabis lighting company to offer these features, which are now standard among many top commercial cannabis growers. These attributes help cultivators produce the highest quality crops at the lowest prices for consumers.
    A Growing Opportunity
    Solis Tek has experienced tremendous growth over the past several quarters as it capitalizes on increasing demand for its lighting solutions. In addition to its lighting products, the company recently expanded into the nutrients business with the launch of TERPENEZ™ in an effort to increase revenue and expand profit margins by upselling its existing customers. These efforts could unlock even more value for shareholders over the long-term and potentially improve its valuation multiples as it enters the $32 billion nutrient/additive sector.
    Last quarter, the company reported revenue that increased 14.8% to $2,441,289 and a gross profit of $919,879. The company also introduced a new lighting controller at the end of the second quarter. These developments could support further revenue growth throughout the remainder of the year given the synergies with its existing customers and product lines.
    "By leveraging the same client base as our existing lighting products, we expect the launch of the new nutrients division to drive significant revenue growth for Solis Tek, while expanding margins due to the increased efficiencies derived from utilizing existing sales and distribution channels," says CEO Dennis Forchic. "Solis Tek remains ideally positioned to capitalize on the rapidly expanding legalization of medical and adult-use cannabis."
    Please follow the link to read the full article: http://www.cannabisfn.com/solis-tek-...ighting-study/
    Reply With Quote  
     

  9. #34  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Baystreet Staff - Thursday, September 28, 2017


    Solis Tek to Present at The MicroCap Conference on October 5th in New York City at the Essex House (Alan Lien, Co-Founder and President of Solis Tek, to also participate as speaker on cannabis investing panel)http://www.baystreet.ca/viewarticle.aspx?id=476508
    Reply With Quote  
     

  10. #35  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    A Little-Known Standout With Huge Potential Upside

    There are still some small companies that have yet to be discovered by Wall Street. Solistek (SLTK) could be one of these exceptions, and this stock may offer triple-digit upside to investors should the company continue to grow revenue as the marijuana industry takes off, and if investors start to take notice of this undiscovered name.
    Solis Tek provides high-quality lighting equipment and supportive nutrients to the marijuana industry, with revenues of $8.5 million last year. Gross profit was over $3 million, and the company just announced that revenue in the second quarter of this year grew a rapid 15% over the same quarter in 2016. Their products are sold by over 500 re-sellers in the U.S., Canada, and parts of Europe, and the company even won Dope Magazine's Best Lighting Company Award in 2016. SLTK's management own about 75% of the company's stock, which means they are highly incentivized to maximize value to shareholders - themselves included.
    Here's what makes it a standout - while the above companies are trading at high multiples of their recent sales figures, SLTK is still undiscovered. Applying a 15x sales multiple to SLTK's $8.5 million in 2016 revenue, like that of MCIG, would imply a potential share price of $3.40 if the market started to pick up on this price disparity.
    Discovering price disparities is exactly how smart traders make their profit, and we think SLTK's execution in 2017 could justify major price appreciation as Wall Street picks up on this supplier.
    https://finance.yahoo.com/news/why-c...120000082.html
    Reply With Quote  
     

  11. #36  
    RX Junior
    Join Date
    Oct 2017
    Location
    LA
    Posts
    12
    Already bought!
    Reply With Quote  
     

  12. #37  
    RX SemiGod tmader7's Avatar
    Join Date
    Oct 2006
    Location
    Muleshoe, TX
    Posts
    14,750
    I got some RX'ers into Aphria and Aurora, Canadian firms. We're up nicely on the two. Got one laggard, Cara Therapeutics, but I'm more than comfortable holding the stock. If you aren't holding weed, missing the boat. Pain management is the next frontier, they're gonna kill the fat hog.

    ~T~
    Reply With Quote  
     

  13. #38  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Solis Tek, Inc. Enhances its Digital Lighting Product Offerings; Introduces Controller to Enable Commercial Growers to Take Complete Control of Lighting Environment






    MarketwiredOctober 17, 2017









    (no caption)Click here for high-resolution version
    More

    CARSON, CA--(Marketwired - October 17, 2017) - Solis Tek (SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., announced today the availability of its lighting controller, which enables commercial growers to harness more control of its garden's lighting environment.
    "For nearly a decade, Solis Tek has led innovation in the cannabis lighting sector," said Dennis G. Forchic, Chief Executive Officer of Solis Tek. "The controller is the next step in our lighting evolution, enabling growers to take more control and customize their growing experience, which in turn increases yield, ROI and enables them to grow better."
    The Solis Tek Controller works with up to 300 lights at once and allows growers to manage multiple lighting cycles, located in different rooms/locations. Additional features include:

    • Precise canopy temperature monitoring that can be connected to up to 25 sensors
    • Customized sunrise and sunset options, enabling growers to run lighting cycles based on their plants' unique needs
    • Data analytics that track a garden's events
    • High temperature auto dim and shut off that automatically reacts based on room temperature
    • Energy efficient cloud cover to mimic the true nature of the sun when full intensity light is not needed

    Today, Solis Tek is recognized as a leading innovator in the cannabis lighting sector with the world's top commercial growers utilizing the Company's HID (high-intensity discharge) lights. Solis Tek was the first company to provide Ignition Control, which is designed to prevent surges and breaker overloads by igniting lamps one at a time based on load stability, and SenseSmart, which is a pre-ignition diagnostic check to ensure that the lighting system is safe and working properly.
    Forchic continued, "The controller provides a level of versatility not found in any other product on the market, specific to cannabis or others crops. For example, if a grower wishes to run their lights on a 22-hour cycle versus a 24-hour cycle that is possible. Or, if their plants do not need a full intensity light during a particular period, they can create an environment which mimics a cloud passing by."
    To be added to the Solis Tek email distribution list, please email SLTK@kcsa.com with 'SLTK' in the subject line.
    About Solis Tek
    Solis Tek is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's lighting solutions to increase yield, lower costs and grow better to maximize their return on investment. In 2017, Solis Tek introduced an organic nutrient line. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information, please visit our website, www.solis-tek.com.
    Safe Harbor Statement
    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
    Image Available: http://www.marketwire.com/library/Mw...1622609416.jpg






    Reply With Quote  
     

  14. #39  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    SLTK https://rumbletalk-images-upload.s3....20oct%20v2.rtf

    The Biggest Marijuana Deal In Years Validates Little SLTK’s Upside Potential

    Investors See Big Validation In Latest Cannabis Deal, SLTK Could Trade To Multiples Of Current Price

    • Constellation Brands (NYSE:STZ) (NYSE:STZ.B) takes CAD$245mln, 10% stake in marijuana grower Canopy Growth (CA:WEED)(OTC:TWMJF), validating this emerging industry.
    • Fortune 500 companies are looking to participate, and they’re putting money to work in companies that are executing on their businesses with real revenue and growth potential.
    • SLTK has been growing revenue consistently in this vertical, and with increased validation the stock is poised for huge upside to catch up to peers. P/S comparison suggests multiples of possible upside through price discovery.

    Beverage supplier Constellation Brands (NYSE:STZ) (NYSE:STZ.B), the owner of Corona and one of the largest suppliers of alcoholic drinks in the U.S. and Canada, just took a tremendous CAD$245 mln (US$190 mln) stake in Canopy Growth Corp. (TSE:CGC) (OTCMKTS:TWMJF) (CA:WEED) in order to own 9.9% of the company. This values Canopy Growth at over 61x their fiscal 2017 sales, and 38x this year’s estimated sales, an encouraging figure for other companies operating in this space.

    But the investment goes far beyond just an interest in the company. Canopy Growth and Constellation will work intimately on consumer analytics, marketing and branding, as well as collaborate on the development and marketing of future cannabis-based beverages.

    The biggest deal in cannabis in years demonstrates just how great the appetite is for this blossoming industry among larger companies. Investors have just begun to see the investments and partnerships that large companies will be inking in the next decade, which sets up quality companies that are executing on their businesses, like Solis Tek Inc (OTCMKTS:SLTK), for potentially big upside.

    This is exceptional validation of this blossoming industry, but it’s not the first of its kind. We’ve seen Scotts Miracle-Gro (NYSE:SMG) make a concerted push into the marijuana space as well through its Hawthorne subsidiary, which is focused on hydroponics and similar growth mediums. The company has made consistent investments, totaling more than $200 mln in a few years, in the lighting, materials, and supplies that support cannabis growers like Canopy Growth Corp.

    Clearly, large companies see the future of cannabis. Investors should be positioning the same way.

    Why Canopy Growth And Why Now?

    The answer is growth and quality execution. First and foremost the market opportunity is immense. Legal marijuana, for medicinal or recreational use, generated $7 billion in the U.S. in 2016. Analysts at Cowen and Company expect that to grow to $25 billion by 2020, and $50 billion by 2026. State laws are lining up in that direction with almost half of the country having legalized cannabis in one form or another as of fall 2017.

    Second, Canopy Growth is executing well on their business plan and generating revenue, unlike many other small companies in the industry. Canopy brought in almost $40 million in revenue through the summer of this year, and the growth has been steady with improving gross margins. Canopy is steadily proving that they’re a real player and here to stay, and the large Constellation investment speaks to that.

    Execution is key, and investors have noticed. TWMJF is up 160% in the last 12 months.

    Or take Aurora Cannabis Inc. (OTC: ACBFF), for instance, which also trades on Toronto’s venture exchange and is another company focused on growing and selling medical marijuana. The stock delivered huge 312% gains in 2016 and has done an excellent job of monetizing their business in the last two years: Aurora delivered $18 million in sales so far in 2017.

    Quiet SLTK Has Been Executing, Stock Ready to Explode Higher With Innovation
    Solis Tek has been executing extremely well in this market, credited with some of the biggest innovations in the cannabis grow light space over the last 5 years and growing revenue. Grow lighting is an overlooked but HIGHLY lucrative space. The global cannabis grow light market is expected to reach $8.6 billion by 2025 according to Grand View Research.
    Solis Tek’s digital ballast, for example, was designed with Ignition Control™ sequential lamp ignition and self-diagnostic safety systems to ensure everything is running smoothly and efficiently. That's resulted in some high-profile customers, including GB Sciences (OTCQB:GBLX), three-time US Cannabis Cup winner for Best Flowers Kyle Kushman, and Colin Gordon of Ethos Genetics.
    In fact, a third party independent test of six lighting products serving the commercial cannabis sector conducted by Light Laboratory Inc confirmed that Solis Tek's digital lighting solutions scored highest in terms of overall value for cultivators. Grow lights are critical to facilitating the growth of healthier plants throughout the growth cycle. Some products are better not only because they enhance the growth capabilities, like SLTK's, but also because they can conserve energy when used correctly.
    With nearly $2.5 million in sales last quarter alone, SLTK offers a rare pure-play opportunity in the cannabis industry. The company’s $10 million potential run-rate this year, with gross margins of 37%, are rare in this emerging industry. SLTK could be approaching profitability in the very near-term with the right sales growth, and the opportunity is a big one - Grand View Research expects a CAGR in the growth light space of 14%! And most recently, the company has diversified, launching a terpene-enhancing nutrient line called Terpenez, which uses all-natural ingredients to increase yield, lower cost, and grow healthier plants.
    SLTK is rapidly creating a one-stop, top-quality provider for cannabis cultivators. And they're doing so without ever touching the plant, reducing the direct risk associated with federal law.
    Finally, SLTK trades at a very conservative valuation based on our 2017 estimate of approximately $10 million in revenue, or a Price/Sales ratio of 4x. Compare that to the P/S of Canopy Growth, which has now reached 66x based on CAD$39.8 mln in their fiscal 2017. A move of even half this magnitude to trade in line with this peer would value SLTK at over $5.00, and we think a revaluing higher is not out of the question quickly with continued execution on the part of SLTK.
    Reply With Quote  
     

  15. #40  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Solis Tek Announces Closing of $2.5 Million Financing






    MarketwiredNovember 13, 2017






    ARSON, CA--(Marketwired - November 13, 2017) - Solis Tek (SLTK) ("Solis Tek" or "Company"), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., announced today the Company has closed on its recent round of financing by securing $2.5 million of which $1.75 million came through a secured convertible debenture with a single institutional investor.
    Solis Tek's Chief Executive Officer Dennis G. Forchic, stated, "We are pleased to have secured funding that will enable Solis Tek to capitalize on the robust commercial opportunity that lies before us. The proceeds will enable the Company to assure our supply chain execution and maintain inventory levels that can meet customer demand for our industry-leading lighting products. In particular, we are excited to ramp commercial activities, fulfill initial orders, and build inventory for our recently-launched Controller, which enables growers to customize their growing experience by mimicking the conditions of natural sunlight, and to automate production for our Nutrient Line, from which we soon plan to launch our second commercial product."
    For more information on the financing, please read the 8-K which was filed and posted at www.sec.gov.
    About Solis Tek
    Solis Tek is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and adult use space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's digital lighting solutions to increase yield, lower costs and grow better. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information please visit our website www.solis-tek.com.
    Reply With Quote  
     

  16. #41  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    November 14, 2017


    Comment

    CARSON, CA--(Marketwired - November 14, 2017) - Solis Tek Inc. (SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., today reported financial results for the quarter and nine month period ended September 30, 2017.
    Financial Update

    • Third Quarter 2017 revenues of $1.99 million; up 6% over the same period in 2016
    • Revenues of $7.34 million for the first nine months of 2017; up 11.4% over the same period in 2016
    • Third Quarter 2017 gross profit of $671 thousand; up 5% over the same period in 2016
    • Gross profit of $2.71 million for the first nine months of 2017; up 14.5% over the same period in 2016

    Business Update

    • Successful launch of proprietary Digital Lighting Controller to unprecedented market response and demand
    • Testing initialized for second Zelda Horticulture, Inc. nutrient product
    • Independent, third party test of six lighting companies scored Solis Tek's Digital Lighting solution highest in terms of overall efficiency and value for cultivators

    Subsequent Event

    • In November, 2017, Solis Tek closed on a financing that provided $2.5 million in new capital to support supply chain fulfillment and nutrient line automation

    "We've significantly expanded our product portfolio in the third quarter and the increased demand for our products has continued," commented Dennis G. Forchic, Chief Executive Officer of Solis Tek. "We are particularly excited about the response to our new Digital Lighting Controller. This device complements our existing upgraded product line and enables cultivators to schedule and monitor their grow rooms, thus increasing the grower's yield and ROI. Initial demand for the Controller exceeded expectations. With the recent funding round now complete we are excited to be able to increase inventory levels across the board to meet projected demands."
    Mr. Forchic continued, "With the successful completion of our recently announced financing transaction that resulted in more than $2 million in capital, Solis Tek is well positioned to realize sustained supply chain execution, thus maintaining healthy inventory levels of key products across our product portfolio to support continued revenue growth. We also plan to use the proceeds from this financing to automate production of our Nutrient Line, which is rapidly moving towards introducing its second commercial product. We remain excited by the demand trends we are seeing across both our lighting and nutrient units, which will leverage the same distribution-supply channels and client base, spearheading our planned drive toward significant revenue growth and expanded margins for Solis Tek. We see tremendous opportunity for Solis Tek as we position the Company for dynamic growth in 2018 and beyond."
    Financial Results for the Quarter Ended September 30, 2017
    For the third quarter of 2017, revenues were $1.99 million, representing a 6% increase over the same period in 2016. These increases were driven by increased market penetration among hydroponic customers and commercial facilities. Cost of revenues increased 7% over the same period in 2016, modestly lowering gross margin to 33.7%, compared with 34.1% for the same period in 2016.
    Selling, general, and administrative expenses were $2.05 million in the third quarter of 2017, up 167% over the same period in 2016, due primarily to cash and stock-based compensation expenses to support a broad campaign to increase Solis Tek's industry and investment community visibility and, to a lesser extent, increased marketing and payroll related expenses.
    Stock compensation expense was $556,000 for the third quarter of 2017, compared with $25,000 in the same period in 2016. Research and development expenses were $82,500, 42% higher than the same period in 2016.
    Net loss for the third quarter of 2017 was $1.49 million, or $0.04 per share, compared with a net loss of $173,460, or $0.01 per share for the same period in 2016, again due primarily to cash and stock-based compensation expenses.
    As of September 30, 2017, the Company had $194,000 in cash, compared with $276,000 at December 31, 2016.
    Financial Results for the Nine Month Period Ended September 30, 2017
    For the nine months ended September 30, 2017, revenues were $7.34 million, representing an 11.4% increase over the same period in 2016. These increases were driven by increased market penetration among hydroponic customers and commercial facilities. Cost of revenues increased 9.6% over the same period in 2016, resulting in gross margin of 37%, up from 35.9% for the same period in 2016.
    Selling, general, and administrative expenses were $9.21 million in the nine months ended September 30, 2017, up 303% over the same period in 2016, due primarily to cash and stock-based compensation expenses to support a broad campaign to increase Solis Tek's industry and investment community visibility and, to a lesser extent, increased marketing and payroll related expenses.
    Stock compensation expense was $5,361,046 for the nine months ended September 30, 2017, compared with $86,000 in the same period in 2016. Research and development expenses were $247,770 in the nine months ended September 30, 2017, 44% higher than the same period in 2016.

    Net loss for the nine months ended September 30, 2017 was $6.83 million, or $0.18 per share, compared with a net loss of $163,657, or $0.01 per share for the same period in 2016, again due primarily to cash and stock-based compensation expenses.
    To be added to the Solis Tek email distribution list, please email SLTK@kcsa.com with SLTK in the subject line.
    About Solis Tek
    Solis Tek is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's lighting solutions to increase yield, lower costs and grow better to maximize their return on investment. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information, please visit our website, www.solis-tek.com.
    Safe Harbor Statement
    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. The Company undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
    Solis Tek Inc.
    Condensed Consolidated Balance Sheets
    September 30,
    2017
    December 31,
    2016
    (Unaudited)
    ASSETS
    CURRENT ASSETS
    Cash $ 194,129 $ 275,783
    Accounts Receivable, net of allowance for doubtful accounts of $381,937 and $359,395 865,429 628,691
    Inventories 1,769,638 2,880,804
    Prepaid expenses and other current assets 229,004 75,109
    Total current assets 3,058,200 3,860,387
    Property and equipment, net 155,025 204,936
    Other assets 37,154 32,071
    TOTAL ASSETS $ 3,250,379 $ 4,097,394
    LIABILITIES AND SHAREHOLDERS' EQUITY
    CURRENT LIABILITIES
    Accounts payable and accrued expenses $ 939,628 $ 552,057
    Due to related party vendor 398,656 1,083,764
    Note payable - related parties 545,000 265,000
    Amount due to related parties 160,153 134,086
    Capital lease obligations, current portion 12,871 13,711
    Loans payable, current portion 7,914 8,262
    Total Current Liabilities 2,064,222 2,056,880
    Capital lease obligations, net of current portion 260 9,665
    Loans payable, net of current portion 20,159 25,958
    Notes payable related parties, net of current portion 600,000 600,000
    Total liabilities 2,684,641 2,692,503
    Commitments and contingencies
    Shareholders' Equity
    Preferred stock, no par value, 20,000,000 shares authorized; no shares issued and outstanding - -
    Common stock, $0.001 par value, 100,000,000 shares authorized; 37,959,534 and 29,721,998 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 37,959 29,722
    Additional paid-in-capital 8,778,651 2,795,842
    Accumulated deficit (8,250,872 ) (1,420,673 )
    Total Shareholders' Equity 565,738 1,404,891
    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 3,250,379 $ 4,097,394

    Solis Tek Inc.
    Condensed Consolidated Statements of Operations
    Three months ended
    September 30,
    Nine months ended
    September 30,
    2017 2016 2017 2016
    (Unaudited) (Unaudited)
    Sales $ 1,993,865 $ 1,877,000 $ 7,336,980 $ 6,587,498
    Cost of goods sold (1) 1,322,497 1,236,536 4,625,210 4,219,412
    Gross profit 671,368 640,464 2,711,770 2,368,086
    Operating expenses
    Selling, general and administrative expenses 2,050,189 767,239 9,206,076 2,286,464
    Research and development 82,500 57,500 247,770 172,500
    Total operating expenses 2,132,689 824,739 9,453,846 2,458,964
    Loss from operations (1,461,321 ) (184,275 ) (6,742,076 ) (90,878 )
    Interest expense, net of interest income (28,190 ) (26,885 ) (84,010 ) (77,279 )
    Interest income - - - 4,500
    Loss before income taxes (1,489,511 ) (211,160 ) (6,826,086 ) (163,657 )
    Provision (benefit) for income taxes - (37,700 ) 4,113 -
    NET LOSS $ (1,489,511 ) $ (173,460 ) $ (6,830,199 ) $ (163,657 )
    BASIC AND DILUTED LOSS PER SHARE $ (0.04 ) $ (0.01 ) $ (0.18 ) $ (0.01 )
    WEIGHTED - AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED 37,079,972 29,659,498 37,482,508 29,623,868
    (1) Included in cost of goods from related party $ 977,784 $ 723,387 $ 3,607,090 $ 3,309,941
    https://finance.yahoo.com/news/solis...120500802.html




    Reply With Quote  
     

  17. #42  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Reply With Quote  
     

  18. #43  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    Institutional Financing & Revenue Growth Should Set Up SLTK For Big 2018 Returns






    ACCESSWIRENovember 15, 2017






    • In the cannabis industry, ancillary products and services have attracted significant investment, accounting for the majority of recent financings and M&A according to Viridian Capital
    • The smart money is in. Institutional financing and strong third quarter results for Solis Tek (SLTK) indicate potentially big 2018 with new product lines and inventory prep ahead of Canadian legalization decision next summer

    NEW YORK, NY / ACCESSWIRE / November 15, 2017 / The smart money is falling in line, and an impressive institutionally backed financing from Solis Tek Inc (SLTK) this week could mean a big 2018 for the small cannabis player. This developer of top-echelon growth and production solutions for marijuana companies raised $2.5 million in new cash on Monday, $1.75 million of which came directly from a single institutional supporter and could even prove non-dilutive, signaling the credibility of this financing.
    Conspicuously, Solis Tek CEO Forchic may have indicated just how big 2018 could be in Monday's press release, saying the proceeds will "...assure our supply chain execution and maintain inventory levels that can meet customer demand..." In the wake of launching a brand new nutrient line and lighting controller, Solis Tek could be lined up for a quality next few months as orders turn into revenue.
    What makes 2018 so important? For one, Canada may be on the verge of country-wide cannabis legalization next summer, and Canadian growers are already ramping up in anticipation. Aurora Cannabis Inc (ACBFF) is now up more than 90% this month, fueled by rising revenue and expectations that it can secure a strong position in Quebec's legalized cannabis market. These are Solis Tek's potential customers, and as they continue to grow, it's highly likely that so will Solis Tek.
    Most traders and investors are well-aware of the boom in cannabis-focused companies and their stocks. The Viridian Cannabis Stock Index, which tracks the performance of 50 publicly traded cannabis companies, returned a tremendous 236% in 2016 as investors and traders anticipated new cannabis markets coming online after the elections in November, and the index climbed another 35% in the first months of 2017.
    Companies like Toronto-traded Canopy Growth Corp (TSX:WEED, OTC PINK:TWMJF), which grows legal marijuana for the Canadian medical market, climbed almost 200% in 2016 and 122% so far in 2017. The company has done an amazing job of monetizing their business in the last two years, delivering almost $40 million in sales and a massive partnership with Constellation Brands, Inc.(STZ) just last month.
    But many cannabis companies, and their shares, haven't delivered for investors in the same way. The unfortunate thing is the state of some of these small companies' Income Statements - abysmal. Zero-to-no revenue with high expenses and a path to revenue growth based only on the "hope" that recreational and medical marijuana go mainstream, and they get a chunk of the business. Finding cannabis companies that are executing well isn't easy, but SLTK is one of the rare companies generating sales, and with bright prospects for 2018.
    The problem isn't that many small companies aren't real - many of them have experienced management teams and may have bright futures. It's that investors aren't seeing the results they'd hoped to see--rapidly--since legalization in key states like California. In other words, the excitement of 2016 hasn't turned into measurable revenue and stock performance in 2017.
    State laws are lining up in the right direction, with almost half of the country having legalized cannabis in one form or another. Legal marijuana generated $7 billion in the U.S. last year, which is expected to grow to $25 billion by 2020, and $50 possibly billion by 2026.
    So what's the disconnect? Most of these sales aren't trickling down to the few public companies going after this growing but highly competitive market.
    The Market Is Real, But It May Not Be Where You Thought...
    What most investors don't realize is that while it may be sexy to invest in companies that grow, process, or sell marijuana, the reality is that the much of the smart money has looked elsewhere, to "Ancillary" businesses, to reduce risk and find big upside.
    That is, besides the more established growers, sophisticated funds gravitate towards companies that service or supply the growers, rather than own the growers themselves.
    The data speaks for itself. According to Viridian Capital Advisors, 70% of the M&A and capital raises/financings in October in the cannabis space occurred around companies that do NOT touch the plant - so-called "Ancillary Products and Services."
    In reality, the smart money is participating in deals around peripheral companies, like those that provide services or products TO the companies that "touch the plant."

    Take note of what Scott's Miracle-Gro (SMG) has poured into their Hawthorne subsidiary in the last few years - almost $300 mln in investment dollars for acquisitions and development. Grow lighting, for instance, isn't where most cannabis investors would think to look first, but it's an incredibly lucrative space. According to Grand View Research, the global cannabis grow light market is expected to reach $8.6 billion by 2025! Case in point, Scott's acquired a 75% interest in European lighting company Gavita for $136.2 mln in 2016, valuing this non-public company at nearly $200 mln based on their lighting products alone.
    Similar SLTK Is Executing, Ready To Rocket With Financing Complete
    Solis Tek, meanwhile, is one of THE premier grow-light distributors in the U.S., generating $7.34 million in the first 9 months of this year, and a compelling 12% growth over the same period last year. Solis Tek is one of the few small-cap cannabis companies with a solid business and growing sales - and they don't even touch the plant.
    Grow lights are critical to facilitating healthier plants throughout the growth cycle, and Solis Tek has been selected as one of THE top U.S. providers on multiple occasions and by multiple third parties: an independent test of six lighting products conducted by Light Laboratory Inc confirmed that Solis Tek's digital lighting solutions scored highest in terms of overall value for cultivators; and they won the DOPE Industry Awards for "Best Lighting Company".
    The company has been making great headway in the industry for the last few years, and with the recent launch of Terpenez, their own nutrient product for cannabis growers, and a second nutrient to follow imminently, the company is positioned for a possibly huge 2018 as more and more states legalize regional cannabis production. This week the company completed an institutionally-supported financing with one institution alone buying $1.75 mln of stock, according to the company. This strong financing has the potential to be non-dilutive, in fact, as much of the total $2.5 mln raised is structured as convertible debt.
    What could this mean? First, management has been signaling that demand for recently launched products is significant, and this capital infusion will be used for inventory preparation. Second, preparing and launching their first and second nutrient formulations, the first of which is called Terpenez, puts Solis Tek into an entirely new and high-margin vertical; they're suite of services should be that much more attractive to larger companies like Canopy Growth or Aurora Cannabis. Finally, improving the ownership structure with institutional backers offers validation for other public investors, and SLTK could be read for primetime in 2018.
    The real kicker with SLTK is how incentivized management is to execute: CEO Dennis Forchic owns 15% of the company, and insiders combined own about 70% of the company, demonstrating these executives' confidence in the business. As Canada and more states bring marijuana sales online in the next year, SLTK has the right recipe for huge growth.
    About One Equity Stocks
    One Equity Stocks is a leading provider of research on publicly traded emerging growth companies. Our team is comprised of sophisticated financial professionals that strive to find the companies and management teams that will outperform the market and deliver investment returns to our subscribers. We are not a licensed broker-dealer and do not publish investment advice and remind readers that investing involves considerable risk. One Equity Stocks encourages all readers to carefully review the SEC filings of any issuers we cover and consult with an investment professional before making any investment decisions. One Equity Stocks is a for-profit business and is usually compensated for coverage of issuers. In the case of SLTK, we are reimbursed for actual costs of this distribution and have received 100,000 shares of restricted stock for Business Development, Capital Markets and Research Services. Readers should always assume that we will sell some or all of our position as soon as the 180 day anniversary of the stock's issuance date. Please contact us at info@investorclick.net for additional information or to subscribe to our intelligence service.
    SOURCE: One Equity Stocks
    Reply With Quote  
     

  19. #44  
    RX Senior brucefan's Avatar
    Join Date
    Jan 2005
    Location
    wellington
    Posts
    1,989
    SLTK Initiating coverage of Solis Tek, Inc. with a Speculative Buy rating and twelve-month price target of $3.00 pershare

    http://www.taglichbrothers.com/compa...k-11202017.pdf
    Reply With Quote  
     

Posting Permissions
  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •